These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2934800)
1. The effects of topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis. Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H Scand J Immunol; 1985 Nov; 22(5):471-7. PubMed ID: 2934800 [TBL] [Abstract][Full Text] [Related]
2. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy. Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908 [TBL] [Abstract][Full Text] [Related]
3. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241 [TBL] [Abstract][Full Text] [Related]
4. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Baker BS; Swain AF; Fry L; Valdimarsson H Br J Dermatol; 1984 May; 110(5):555-64. PubMed ID: 6232938 [TBL] [Abstract][Full Text] [Related]
5. Skin polyamine levels in psoriasis: the effect of dithranol therapy. Bohlen P; Grove J; Beya MF; Koch-Weser J; Henry MH; Grosshans E Eur J Clin Invest; 1978 Aug; 8(4):215-8. PubMed ID: 100325 [TBL] [Abstract][Full Text] [Related]
6. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis. Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824 [TBL] [Abstract][Full Text] [Related]
7. The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis. Saihan EM; Albano J; Burton JL Br J Dermatol; 1980 May; 102(5):565-9. PubMed ID: 6248098 [TBL] [Abstract][Full Text] [Related]
8. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid. Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis. Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521 [TBL] [Abstract][Full Text] [Related]
10. Psoriasis treatment: faster clearance when UVB-dithranol is combined with topical clobetasol propionate. Lidbrink P; Johannesson A; Hammar H Dermatologica; 1986; 172(3):164-8. PubMed ID: 3699218 [TBL] [Abstract][Full Text] [Related]
11. Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin. Czernielewski J; Juhlin L; Shroot S; Brun P Acta Derm Venereol; 1985; 65(2):97-101. PubMed ID: 2408430 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of cyclosporine A on Langerhans cells and regulatory T-cell populations in severe psoriasis: an immunohistochemical and flow cytometric analysis. Horrocks C; Duncan JI; Sewell HF; Ormerod AD; Thomson AW J Autoimmun; 1990 Oct; 3(5):559-70. PubMed ID: 2252524 [TBL] [Abstract][Full Text] [Related]
13. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Ashworth J; Booker J; Breathnach SM Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity. Ashworth J; Kahan MC; Breathnach SM J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952 [TBL] [Abstract][Full Text] [Related]
15. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment. Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012 [TBL] [Abstract][Full Text] [Related]
16. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy. Yamamoto T; Nishioka K Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829 [TBL] [Abstract][Full Text] [Related]
17. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells. Prens EP; Benne K; van Joost T; Benner R J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638 [TBL] [Abstract][Full Text] [Related]
18. The effect on epidermal DNA synthesis of a combination of topical steroid with either dithranol or tar as used for psoriasis. Clement M; Hehir M; Phillips H; du Vivier A Br J Dermatol; 1983 Sep; 109(3):327-35. PubMed ID: 6615719 [TBL] [Abstract][Full Text] [Related]
19. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. Nestle FO; Turka LA; Nickoloff BJ J Clin Invest; 1994 Jul; 94(1):202-9. PubMed ID: 8040262 [TBL] [Abstract][Full Text] [Related]
20. Effects of dithranol on neutrophil superoxide generation in patients with psoriasis. Kavanagh GM; Burton JL; Donnell VO Br J Dermatol; 1996 Feb; 134(2):234-7. PubMed ID: 8746335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]